1AI 14.3% 0.6¢ algorae pharmaceuticals limited

Ann: LCT Interim CEO Appointed, page-11

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 12,377 Posts.
    lightbulb Created with Sketch. 6363
    I believe there was value in Immupell.

    It allowed the delivery of stem cells into the human body by stealth.

    The delivery system did not trigger an infection alert to the human body.

    Even today delivery of stem cells circa 50% are destroyed by the Humans body immune system with in 48 hours of delivery.
    In most cases drugs are given to the patient to reduce their immune system to reduce the human bodies ability to destroy what it believes is an infection.

    2nd , I believe the greatest error was the double barreled end point for the trial.
    to reduce and improve , should have just been reduce the impact of Parkinsons.

    Best of luck to all holders ,,, hope this company is pheonixed into a profitable company for all....
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.6¢
Change
-0.001(14.3%)
Mkt cap ! $10.12M
Open High Low Value Volume
0.6¢ 0.6¢ 0.6¢ $477 79.44K

Buyers (Bids)

No. Vol. Price($)
16 6813716 0.5¢
 

Sellers (Offers)

Price($) Vol. No.
0.6¢ 20556 1
View Market Depth
Last trade - 15.34pm 01/11/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.